Sponsored content By Mirus Bio LLC How manufacturers can beat the race against time to achieve optimal adeno-associated virus (AAV) titers reliablyViral-based gene therapies (GTs) represent a new frontier in medicine, offering hope to patients who previously had few, if any, treatment options. As therapeutic developers increasingly target polygenic indications with larger patient populations, including […]
